Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell Lines01:16

Cell Lines

7.1K
A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
7.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digital front door technologies to pre-assess people before assessment for NHS Talking Therapies [HTE10055]: early value assessment.

Health technology assessment (Winchester, England)·2026
Same author

Expression of <sup>2</sup>H, <sup>13</sup>C, <sup>15</sup>N-labeled NIST-Fab fragment in the methylotrophic yeast <i>Komagataella phaffii</i> for nuclear magnetic resonance studies.

EPJ web of conferences·2026
Same author

Targeting microbiota-generated acetaldehyde to prevent progression of metabolic dysfunction-associated steatotic liver disease.

Cell metabolism·2026
Same author

Prediction of Delirium Risk in Mild Cognitive Impairment Using Time-Series Data, Machine Learning and Comorbidity Patterns - A Retrospective Study.

IEEE journal of biomedical and health informatics·2025
Same author

Profiling bile acid composition in bile from mice of different ages and sexes.

Frontiers in physiology·2025
Same author

Evaluation of "Difficult-to-Express" Monoclonal Antibodies in a CHO-Based Hybrid Site-Specific Integration System Under Industrially Relevant Conditions.

Biotechnology journal·2025
Same journal

Molecular Mechanisms of Cellulase Biosynthesis in Trichoderma reesei: Regulatory Networks, Secretion Pathways, and Environmental Modulation.

Biotechnology journal·2026
Same journal

The Impact of Collection Protocol on the Yield and Purity of Mesenchymal Stem Cell-Derived Extracellular Vesicles Isolated From Serum-Free Media.

Biotechnology journal·2026
Same journal

Biochemical and Functional Characterization of a Novel GH46 Chitosanase for Efficient Chitooligosaccharide Synthesis.

Biotechnology journal·2026
Same journal

LaeA Orchestrates Iron-Heme Supply and P450 Catalytic Efficiency for Enhanced Echinocandin B Biosynthesis in Aspergillus nidulans.

Biotechnology journal·2026
Same journal

Emerging Bioengineering Technologies in Female Reproduction: Preclinical Advances, Translational Challenges, and Future Outlook.

Biotechnology journal·2026
Same journal

Multi-Enzyme Cascade Reaction of Crude Enzyme Strategy for the Economical and Efficient Bioconversion of Rebaudioside A to Rebaudioside M.

Biotechnology journal·2026
See all related articles

Related Experiment Video

Updated: May 13, 2025

FIBS-enabled Noninvasive Metabolic Profiling
09:16

FIBS-enabled Noninvasive Metabolic Profiling

Published on: February 3, 2014

9.6K

Development and Characterization of the NISTCHO Reference Cell Line.

Hussain Dahodwala1, Irfan Hodzic2, Alexei Slesarev3

  • 1National Institute for Innovation in Manufacturing Biopharmaceuticals, University of Delaware, Newark, Delaware, USA.

Biotechnology Journal
|May 10, 2025
PubMed
Summary
This summary is machine-generated.

NIST developed NISTCHO, a new Chinese hamster ovary cell line, to serve as a reference material for monoclonal antibody production. This well-characterized cell line will improve scientific collaboration and reproducibility in biopharmaceutical research.

Keywords:
NISTCHOcell culturecell line developmentmonoclonal antibodyreference cell linetransgene integration sites

More Related Videos

Generation of Stable Human Cell Lines with Tetracycline-inducible Tet-on shRNA or cDNA Expression
09:51

Generation of Stable Human Cell Lines with Tetracycline-inducible Tet-on shRNA or cDNA Expression

Published on: March 5, 2013

35.2K
A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

22.2K

Related Experiment Videos

Last Updated: May 13, 2025

FIBS-enabled Noninvasive Metabolic Profiling
09:16

FIBS-enabled Noninvasive Metabolic Profiling

Published on: February 3, 2014

9.6K
Generation of Stable Human Cell Lines with Tetracycline-inducible Tet-on shRNA or cDNA Expression
09:51

Generation of Stable Human Cell Lines with Tetracycline-inducible Tet-on shRNA or cDNA Expression

Published on: March 5, 2013

35.2K
A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

22.2K

Area of Science:

  • Biotechnology
  • Cell Line Development
  • Biopharmaceutical Manufacturing

Background:

  • Well-characterized reference materials are crucial for scientific collaboration and reproducibility.
  • Standardized reagents reduce barriers to sharing materials and information within the scientific community.

Purpose of the Study:

  • To develop and characterize a novel recombinant Chinese hamster ovary (CHO) cell line, NISTCHO, for use as a reference material.
  • To establish a robust cell line for the production of the NISTmAb IgG1, a well-defined antibody.

Main Methods:

  • Development of a recombinant CHO cell line (NISTCHO) expressing NISTmAb IgG1.
  • Evaluation of candidate clonal cell lines in fed-batch culture for growth, productivity, and protein quality.
  • Sequencing and PCR-based methods to map transgene integration sites.
  • Independent laboratory validation of the selected NISTCHO cell line.

Main Results:

  • Multiple candidate clonal cell lines demonstrated suitability for growth, productivity, and protein quality.
  • A preferred candidate cell line was selected based on transgene integration site analysis.
  • A base-pair resolution map of the transgene integration site was successfully generated.
  • Validation by an independent laboratory confirmed the robustness of the NISTCHO cell line.

Conclusions:

  • The development of the NISTCHO cell line provides a new, well-characterized reference material for the biopharmaceutical industry.
  • NISTCHO will facilitate interlaboratory studies and enhance reproducibility in monoclonal antibody production.
  • This reference cell line is foundational for future standardization efforts in biomanufacturing.